Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -577,757 | -429,138 | -314,410 | -363,012 | -212,526 |
| Depreciation Amortization | 20,037 | 21,624 | 23,904 | 10,989 | 9,494 |
| Income taxes - deferred | -1,836 | -35,927 | -2,125 | -373 | -6,119 |
| Accounts receivable | -5,680 | -2,957 | -1,051 | -10,622 | -1,623 |
| Accounts payable and accrued liabilities | 9,870 | -3,878 | -3,677 | 10,221 | 3,578 |
| Other Working Capital | 69,551 | -2,791 | 3,799 | 7,451 | 6,144 |
| Other Operating Activity | 191,958 | 171,246 | 134,024 | 172,350 | 89,285 |
| Operating Cash Flow | $-293,857 | $-281,821 | $-159,536 | $-172,996 | $-111,767 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,657 | -8,871 | -6,528 | -28,482 | -11,195 |
| Net Acquisitions | -14,861 | -36,049 | -33,395 | -9,691 | -10,000 |
| Sale Of Investment | N/A | 124,767 | N/A | N/A | N/A |
| Investing Cash Flow | $-28,518 | $79,847 | $-39,923 | $-38,173 | $-21,195 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 96,071 | 49,743 | 18,587 | 8,000 | N/A |
| Debt Issued | N/A | N/A | N/A | 17,411 | 263,384 |
| Debt Repayment | N/A | N/A | -55,000 | -3,074 | N/A |
| Common Stock Issued | 403,532 | 217,245 | 416,216 | 56,548 | 83,819 |
| Other Financing Activity | -187,885 | -85,656 | -205,564 | 0 | -21,205 |
| Financing Cash Flow | $311,718 | $181,332 | $174,239 | $78,885 | $325,998 |
| Exchange Rate Effect | -2,374 | 843 | 915 | -277 | -135 |
| Beginning Cash Position | 36,665 | 56,464 | 80,769 | 213,330 | 20,429 |
| End Cash Position | 23,634 | 36,665 | 56,464 | 80,769 | 213,330 |
| Net Cash Flow | $-13,031 | $-19,799 | $-24,305 | $-132,561 | $192,901 |
| Free Cash Flow | |||||
| Operating Cash Flow | -293,857 | -281,821 | -159,536 | -172,996 | -111,767 |
| Capital Expenditure | -13,657 | -8,871 | -6,528 | -28,482 | -11,195 |
| Free Cash Flow | -307,514 | -290,692 | -166,064 | -201,478 | -122,962 |